Search

Your search keyword '"CERMAK J"' showing total 1,028 results

Search Constraints

Start Over You searched for: Author "CERMAK J" Remove constraint Author: "CERMAK J"
1,028 results on '"CERMAK J"'

Search Results

1. Electrochemical in-situ studies of solar mediated oxygen transport and turnover dynamics in a tree trunk of Tilia cordata

2. Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia

7. Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: HEMATOPOIETIC STEM CELLS OF LOWER-RISK MDS PATIENTS WITH RAPID PROGRESSION SHOW QUIESCENT-LIKE CELL STATE SIMILAR TO THAT OF HIGHER-RISK MDS CELLS

8. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: ACCELERATED FAILURE TIME MODELS AS A CLINICALLY PLAUSIBLE WAY TO DESCRIBE SURVIVAL IN MDS – AN ANALYSIS OF THE IWG-PM DATABASE

9. Topic: AS07-Singular Entities/Subtypes/AS07d-MDS with ring sideroblasts: SF3B1 MUTATIONS AND THEIR IMPACT ON CELLULAR BIOENERGETICS IN MYELODYSPLASTIC SYNDROMES

12. Machine-Learning Algorithm for 24h Detection of Fog and Low Stratus over Europe based on Meteosat-SEVIRI Infrared Bands

14. P095 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: ACCELERATED FAILURE TIME MODELS AS A CLINICALLY PLAUSIBLE WAY TO DESCRIBE SURVIVAL IN MDS – AN ANALYSIS OF THE IWG-PM DATABASE

16. Case Study 'Kranzberger Forst': Growth and Defence in European Beech (Fagus sylvatica L.) and Norway Spruce (Picea abies (L.) Karst.)

20. P729: DEREGULATION OF NONCODING RNAS DERIVED FROM KDM GENES IS ASSOCIATED WITH AZACITIDINE RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

24. Sex Steroids, the Meibomian Gland and Evaporative Dry Eye

33. Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

40. Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

49. O08 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: LYMPHOPENIA IS HIGHLY PREVALENT IN MDS AND PROVIDES ADDITIONAL PROGNOSTIC INFORMATION FOR IPSS-R VERY-LOW AND LOW-RISK PATIENTS. AN ANALYSIS FROM THE EU-MDS REGISTRY

Catalog

Books, media, physical & digital resources